(NXPI) NXP Semiconductors - Overview
Exchange: NASDAQ •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: NL0009538784
Stock:
Total Rating 46
Risk 69
Buy Signal -0.26
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -1.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -22.05 |
| Character TTM | |
|---|---|
| Beta | 1.485 |
| Beta Downside | 1.953 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.47% |
| CAGR/Max DD | 0.21 |
EPS (Earnings per Share)
Revenue
Description: NXPI NXP Semiconductors
NXP Semiconductors N.V. provides semiconductor products in the United States, Germany, Japan, South Korea, Taiwan, Singapore, the Netherlands, Mainland China, Hong Kong, and internationally. The company's product portfolio includes microcontrollers; application processors; communication processors; wireless connectivity solutions, such as near field communications, ultra-wideband, Bluetooth low-energy, Zigbee, Thread, and Wi-Fi and Wi-Fi/Bluetooth integrated SoCs; analog and interface products; radio frequency devices, and security controllers, as well as semiconductor-based environmental and inertial sensors, including pressure, inertial, magnetic, and gyroscopic sensors. Its products are used in various applications, including automotive, industrial and Internet of Things, mobile, and communication infrastructure. The company markets its products to direct sales offices and independent distributors. NXP Semiconductors N.V. was incorporated in 2006 and is headquartered in Eindhoven, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.96 > 1.0 |
| NWC/Revenue: 33.08% < 20% (prev 33.35%; Δ -0.27% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.82b > Net Income 2.02b |
| Net Debt (8.96b) to EBITDA (3.92b): 2.28 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.1m) vs 12m ago -1.46% < -2% |
| Gross Margin: 54.58% > 18% (prev 0.56%; Δ 5402 % > 0.5%) |
| Asset Turnover: 48.17% > 50% (prev 51.73%; Δ -3.56% > 0%) |
| Interest Coverage Ratio: 6.37 > 6 (EBITDA TTM 3.92b / Interest Expense TTM 485.0m) |
Altman Z'' 1.56
| A: 0.15 (Total Current Assets 7.94b - Total Current Liabilities 3.88b) / Total Assets 26.56b |
| B: -0.05 (Retained Earnings -1.35b / Total Assets 26.56b) |
| C: 0.12 (EBIT TTM 3.09b / Avg Total Assets 25.47b) |
| D: -0.08 (Book Value of Equity -1.35b / Total Liabilities 16.11b) |
| Altman-Z'' Score: 1.56 = BB |
Beneish M -2.99
| DSRI: 1.05 (Receivables 1.05b/1.03b, Revenue 12.27b/12.61b) |
| GMI: 1.03 (GM 54.58% / 55.95%) |
| AQI: 1.04 (AQ_t 0.59 / AQ_t-1 0.57) |
| SGI: 0.97 (Revenue 12.27b / 12.61b) |
| TATA: -0.03 (NI 2.02b - CFO 2.82b) / TA 26.56b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of NXPI shares?
As of February 28, 2026, the stock is trading at USD 227.01 with a total of 2,574,226 shares traded.
Over the past week, the price has changed by -2.26%, over one month by -1.05%, over three months by +16.97% and over the past year by +6.64%.
Over the past week, the price has changed by -2.26%, over one month by -1.05%, over three months by +16.97% and over the past year by +6.64%.
Is NXPI a buy, sell or hold?
NXP Semiconductors has received a consensus analysts rating of 4.41.
Therefore, it is recommended to buy NXPI.
- StrongBuy: 19
- Buy: 7
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NXPI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 261 | 15% |
| Analysts Target Price | 261 | 15% |
NXPI Fundamental Data Overview February 28, 2026
P/E Trailing = 29.2481
P/E Forward = 15.5763
P/S = 4.7721
P/B = 5.9993
P/EG = 1.1282
Revenue TTM = 12.27b USD
EBIT TTM = 3.09b USD
EBITDA TTM = 3.92b USD
Long Term Debt = 10.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 12.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.96b USD (from netDebt column, last quarter)
Enterprise Value = 67.50b USD (58.55b + Debt 12.22b - CCE 3.27b)
Interest Coverage Ratio = 6.37 (Ebit TTM 3.09b / Interest Expense TTM 485.0m)
EV/FCF = 25.52x (Enterprise Value 67.50b / FCF TTM 2.65b)
FCF Yield = 3.92% (FCF TTM 2.65b / Enterprise Value 67.50b)
FCF Margin = 21.56% (FCF TTM 2.65b / Revenue TTM 12.27b)
Net Margin = 16.47% (Net Income TTM 2.02b / Revenue TTM 12.27b)
Gross Margin = 54.58% ((Revenue TTM 12.27b - Cost of Revenue TTM 5.57b) / Revenue TTM)
Gross Margin QoQ = 53.58% (prev 56.32%)
Tobins Q-Ratio = 2.54 (Enterprise Value 67.50b / Total Assets 26.56b)
Interest Expense / Debt = 0.88% (Interest Expense 108.0m / Debt 12.22b)
Taxrate = 21.87% (131.0m / 599.0m)
NOPAT = 2.41b (EBIT 3.09b * (1 - 21.87%))
Current Ratio = 2.05 (Total Current Assets 7.94b / Total Current Liabilities 3.88b)
Debt / Equity = 1.22 (Debt 12.22b / totalStockholderEquity, last quarter 10.06b)
Debt / EBITDA = 2.28 (Net Debt 8.96b / EBITDA 3.92b)
Debt / FCF = 3.39 (Net Debt 8.96b / FCF TTM 2.65b)
Total Stockholder Equity = 9.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 2.02b / Total Assets 26.56b)
RoE = 20.73% (Net Income TTM 2.02b / Total Stockholder Equity 9.75b)
RoCE = 14.91% (EBIT 3.09b / Capital Employed (Equity 9.75b + L.T.Debt 10.97b))
RoIC = 11.24% (NOPAT 2.41b / Invested Capital 21.48b)
WACC = 9.54% (E(58.55b)/V(70.77b) * Re(11.39%) + D(12.22b)/V(70.77b) * Rd(0.88%) * (1-Tc(0.22)))
Discount Rate = 11.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.20%
[DCF] Terminal Value 74.55% ; FCFF base≈2.37b ; Y1≈2.66b ; Y5≈3.54b
[DCF] Fair Price = 149.9 (EV 46.69b - Net Debt 8.96b = Equity 37.73b / Shares 251.7m; r=9.54% [WACC]; 5y FCF grow 14.20% → 2.90% )
EPS Correlation: -60.03 | EPS CAGR: -0.16% | SUE: 1.28 | # QB: 1
Revenue Correlation: -41.84 | Revenue CAGR: 1.65% | SUE: 2.04 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.98 | Chg7d=+0.027 | Chg30d=+0.049 | Revisions Net=+6 | Analysts=24
EPS current Year (2026-12-31): EPS=13.93 | Chg7d=+0.004 | Chg30d=+0.133 | Revisions Net=+14 | Growth EPS=+18.0% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=16.76 | Chg7d=+0.014 | Chg30d=+0.104 | Revisions Net=+12 | Growth EPS=+20.3% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.30 (13 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.0% (Discount Rate 11.4% - Earnings Yield 3.4%)
[Growth] Growth Spread = +3.1% (Analyst 11.1% - Implied 8.0%)
P/E Forward = 15.5763
P/S = 4.7721
P/B = 5.9993
P/EG = 1.1282
Revenue TTM = 12.27b USD
EBIT TTM = 3.09b USD
EBITDA TTM = 3.92b USD
Long Term Debt = 10.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 12.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.96b USD (from netDebt column, last quarter)
Enterprise Value = 67.50b USD (58.55b + Debt 12.22b - CCE 3.27b)
Interest Coverage Ratio = 6.37 (Ebit TTM 3.09b / Interest Expense TTM 485.0m)
EV/FCF = 25.52x (Enterprise Value 67.50b / FCF TTM 2.65b)
FCF Yield = 3.92% (FCF TTM 2.65b / Enterprise Value 67.50b)
FCF Margin = 21.56% (FCF TTM 2.65b / Revenue TTM 12.27b)
Net Margin = 16.47% (Net Income TTM 2.02b / Revenue TTM 12.27b)
Gross Margin = 54.58% ((Revenue TTM 12.27b - Cost of Revenue TTM 5.57b) / Revenue TTM)
Gross Margin QoQ = 53.58% (prev 56.32%)
Tobins Q-Ratio = 2.54 (Enterprise Value 67.50b / Total Assets 26.56b)
Interest Expense / Debt = 0.88% (Interest Expense 108.0m / Debt 12.22b)
Taxrate = 21.87% (131.0m / 599.0m)
NOPAT = 2.41b (EBIT 3.09b * (1 - 21.87%))
Current Ratio = 2.05 (Total Current Assets 7.94b / Total Current Liabilities 3.88b)
Debt / Equity = 1.22 (Debt 12.22b / totalStockholderEquity, last quarter 10.06b)
Debt / EBITDA = 2.28 (Net Debt 8.96b / EBITDA 3.92b)
Debt / FCF = 3.39 (Net Debt 8.96b / FCF TTM 2.65b)
Total Stockholder Equity = 9.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 2.02b / Total Assets 26.56b)
RoE = 20.73% (Net Income TTM 2.02b / Total Stockholder Equity 9.75b)
RoCE = 14.91% (EBIT 3.09b / Capital Employed (Equity 9.75b + L.T.Debt 10.97b))
RoIC = 11.24% (NOPAT 2.41b / Invested Capital 21.48b)
WACC = 9.54% (E(58.55b)/V(70.77b) * Re(11.39%) + D(12.22b)/V(70.77b) * Rd(0.88%) * (1-Tc(0.22)))
Discount Rate = 11.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.20%
[DCF] Terminal Value 74.55% ; FCFF base≈2.37b ; Y1≈2.66b ; Y5≈3.54b
[DCF] Fair Price = 149.9 (EV 46.69b - Net Debt 8.96b = Equity 37.73b / Shares 251.7m; r=9.54% [WACC]; 5y FCF grow 14.20% → 2.90% )
EPS Correlation: -60.03 | EPS CAGR: -0.16% | SUE: 1.28 | # QB: 1
Revenue Correlation: -41.84 | Revenue CAGR: 1.65% | SUE: 2.04 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.98 | Chg7d=+0.027 | Chg30d=+0.049 | Revisions Net=+6 | Analysts=24
EPS current Year (2026-12-31): EPS=13.93 | Chg7d=+0.004 | Chg30d=+0.133 | Revisions Net=+14 | Growth EPS=+18.0% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=16.76 | Chg7d=+0.014 | Chg30d=+0.104 | Revisions Net=+12 | Growth EPS=+20.3% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.30 (13 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.0% (Discount Rate 11.4% - Earnings Yield 3.4%)
[Growth] Growth Spread = +3.1% (Analyst 11.1% - Implied 8.0%)